N106 is a first-in-classsarcoplasmic reticulum calcium ATPase (SERCA2a) SUMOylationactivator. N106 directly activates the SUMO-activating enzyme, E1 ligase. N106 can be used for heart failure research^[1].

N106 treatment increases contractile properties of cultured rat cardiomyocytes. N106 increases cell contractility, calcium-transient SERCA2a's ATPase activity and SUMOylation within 10 min of exposure, and these effects are sustained at 24 h in cardiomyocytes^[1].

In a murine model, the half-life of N106 is determined to be ~65.4 min with a C_maxof ~2.24 μM when the mice received 10 mg/kg of N106 by intravenous injection. The oral bioavailability (F%) is 56% and 50%, and terminal elimination half-life (t_1/2) is 19 min^[1].
In vivo, N106 (10 mg/kg) increases cardiac SERCA2A SUMOylation, and significantly improves ventricular function in mice with heart failure^[1].

354.38

Solid

C₁₇H₁₄N₄O₃S

862974-25-2

Room temperature in continental US; may vary elsewhere.

DMSO : 62.5 mg/mL(176.36 mM;ultrasonic and warming and heat to 60℃)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。